MedPath

Examine the endothelial cell alterations in Cornea and central macular thickness in diabetic individuals undergoing phacoemulsification.

Phase 2
Conditions
Health Condition 1: H353- Degeneration of macula and posterior poleHealth Condition 2: O- Medical and Surgical
Registration Number
CTRI/2023/08/056247
Lead Sponsor
Jawaharlal Nehru Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.patients with grade 2-4 cataract according to LOCS III

2.patients with type 2 diabetes mellitus of upto 10 yrs.

3.patients with diabetic retinopathy and macular edema present or absent.

4.patient who is willing to provide informed consent .

Exclusion Criteria

1.traumatic cataract

2.pseudo exfoliation syndrome

3.glaucoma

4.corneal dystrophy

5.complicated cataract which includes lens induced glaucoma

6.post uveitis cataract

7.subluxated lens

8.previous intra- ocular surgery

9.intraoprative complications during cataract surgery

10.high myopia and high hyperopia

11.age younger than 40 yrs

12.preoperative endothelial cell count less than 1000 cells per square mm

13.patients lost to follow up

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath